Orthorexia Nervosa (ON), a problematic fixation on healthy eating, has captured researchers' attention for over a decade. We aimed to develop a brief screening tool for ON that captures physical appearance as a motivating factor, behavioural aspects (rigid control over food selection, consumption and preparation), and nutritional aspects (avoidance of foods considered “impure”). Using a sequential, iterative design, 687 participants completed a self-reported survey across four studies: item identification and selection through exploratory factor analysis (n = 248), testing factorial construct validity with confirmatory factor analysis (n = 127), discriminant validity via known group differences (n = 241), and test-retest reliability of two subsequent administrations of the selected items (n = 71). The final unidimensional version of the short Screening Tool for Orthorexia Nervosa (STONE) comprises eight items. It demonstrated excellent known-group validity and ability to differentiate ON from other types of strict dietary control (e.g., health-based or religious restrictions). Consistent with the view of ON as behaviours aimed at rigid dietary control, avoidance of “impure” foods, and motivation to enhance physical appearance, STONE scores positively related to measures of eating pathology and appearance orientation, while only weakly correlating with obsessive-compulsive tendencies. Based on its psychometric properties, STONE is recommended as a first-level screening tool for ON in research contexts and epidemiology studies among adults. Due to its brevity, it can be easily combined with other scales to explore ON or related phenomena. Future studies should examine convergent validity and test it among adolescents and in different cultural contexts.

No description provided

Introduction: Despite extensive testing efforts in anti-doping work, a persistent gap remains between low doping detection rates and substantially higher estimated doping prevalence in sports. Sample Retention and Further Analysis (SFA), which allows samples to be stored for up to ten years for future testing, offers a potential strategy to close this gap by increasing both detection and deterrence of doping. Methods: This study employs an agent-based modeling approach to simulate interactions among key stakeholders: athletes, anti-doping organizations, laboratories, and event organizers. The model captures athlete decision-making regarding doping, influenced by perceived sanction certainty and swiftness. SFA parameters, such as number of stored samples and duration of storage, were systematically varied to assess their impact. Results: Simulations show that increasing both the quantity of stored/retested samples and the storage duration reduces doping prevalence. A combined approach yields the strongest effect, with higher detection rates and lower doping behavior. However, regression analysis reveals diminishing returns at higher implementation levels, suggesting a non-linear effect. Discussion: The findings provide quantitative evidence that SFA enhances not only detection capacity but also deterrence by increasing the perceived long-term risk of sanctions. Effective SFA implementation requires strategic calibration to optimize impact. These results underscore the potential of SFA as a key component in anti-doping strategies and call for empirical validation and integration of additional behavioral factors in future research.

Background: disordered eating (DE) and eating disorders (ED) can negatively impact athletes’ health, wellbeing, and athletic performance. Objective: this cross-sectional study aims to assess DE risk, body composition, and nutrition knowledge among elite Hungarian athletes. Methods: DE risk was assessed using DESA-6H and EAT-26 scales, nutrition knowledge through the Abridged Nutrition for Sport Knowledge Questionnaire (A-NSKQ), and body composition with the OMRON BF511 device. The data were analyzed using Kendall’s tau correlations, Mann–Whitney U tests, and ROC analysis. Results: a total of 71 athletes participated (39.4% males, mean age = 24.8 years, SD = 4.8 years and 60.6% females, mean age = 24.3 years, SD = 4.3 years). At-risk scores on the DESA-6H scale were recorded for nine athletes (12.7%), while 32.4% scored in the risk zone on the EAT-26, with female athletes in aesthetic, endurance and weight-dependent sports being most affected. Low BF was observed in four males and four females. Nutrition knowledge (49.1%) was below the acceptable threshold. DESA-6H significantly correlated with EAT-26 scores, BMI, sports nutrition knowledge, and A-NSKQ total scores. A statistically significant difference by gender was found in the EAT-26 total score (p = 0.019, d = 0.65). Risk groups significantly differed in A-NSKQ scores (p = 0.026, d = 0.511) and sport nutrition knowledge, specifically (p = 0.016, d = 0.491). Using EAT-26 to identify at-risk athletes and the DESA-6H recommended cut-off, the ROC analysis showed a sensitivity of 29.1% and a specificity of 95.7%. Conclusions: insufficient nutrition knowledge plays a role in being at-risk for DE and ED. These results underscore the need for early detection, early sport nutrition education across all elite athletes, with particular attention to female athletes in aesthetic, endurance and weight-dependent sports, and for monitoring these athletes to prevent DE. Further work is warranted to optimize screening tools such as EAT-26 and DESA-6H for elite athletes.

Background: In the pursuit of sporting success, some elite athletes prioritise peak performance over long-term health, frequently resulting in significant and enduring health consequences. The Enhanced Games (TEG) position themselves as a bold experiment in transhumanism, advocating for the use of performance-enhancing drugs (PEDs), including methods banned by World Anti-Doping Agency (WADA), to push the boundaries of human athletic potential. Objectives: The aim of this study is to explore the perspectives of sport physicians, sport scientists, physiotherapists and other allied healthcare professionals on treating and supporting “enhanced athletes”, with the view of informing future guidelines. Methods: Participants were invited via email and personal contacts within sport medicine communities to complete a brief anonymous survey via QuestionPro™. Descriptive statistics were performed using Excel™ and RStudio™. Results: A total of 323 healthcare professionals responded (82% were sport physicians), among whom 74% expressed a willingness to treat acute lesions and/or chronic diseases in “enhanced athletes”. In comparison, a considerable minority (30%) expressed support for assisting athletes in their use of PEDs and methods under medically supervised conditions, with high consistency across professional roles. A relatively high readiness was observed in sport physicians treating acute (77% versus 58%; p < 0.01) and chronic (75% versus 63%; p = 0.11) diseases for “enhanced athletes”. As far as WADA rules and/or national anti-doping laws apply, this support presupposes compliance with the code and the respective national laws to protect physicians from serious professional, legal and personal consequences. Conclusion: The preliminary findings align with the broader goal of fostering a sport culture that values both peak performance and the short- and long-term health of all participants. These results emphasise the necessity of implementing professional guidelines and comprehensive support systems designed to safeguard the long-term well-being of all athletes and underscore the urgent need for further research into the impact of TEG on sport and its community.